Robert A. Bradway - Chairman, CEO and President, Director at Amgen Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman, CEO and President, Director
Stock Symbol
AMGN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert A. Bradway since 11/23/2024

Holdings reported by Robert A. Bradway for Amgen Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 413K $129M $311.55 May 6, 2025 Direct
Common Stock 90K $28M $311.55 May 6, 2025 By GRAT
Common Stock 90K $28M $311.55 May 6, 2025 By Spousal GRAT
Nqso (Right to Buy) 86K $23.3M $270.44 May 6, 2025 Direct Common Stock

Transactions reported by Robert A. Bradway for Amgen Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.